Skip to content
Shameless Cloning

Search Shameless Cloning

Search superinvestors, stocks, insiders and members of Congress

Q2 2026 13F · SEC CIK 1471085

Bronte Capital Management Pty Ltd.

Hedge fundFiled 2026-08-05 for Q2 2026. Open the filing ↗ · All SEC filings ↗

Reported 13F value
$888.3M
Reported positions
56
Top holdings a year, 3 yrs
+20.0%
Assets under management
$2.3B

Bronte Capital Management Pty Ltd. is a hedge fund that reported 56 positions worth $888.3M in its Q2 2026 13F, filed 2026-08-05. Its largest holdings were Alphabet Inc (GOOGL, 12.3%), Regeneron Pharmaceuticals (REGN, 11.4%), Interactive Brokers Group in (IBKR, 8.7%). A portfolio copying its top holdings returned 20.0% a year over the last 3 years, against 20.4% for the S&P 500.

Bronte Capital Management Pty Ltd. holdings largest 50 of 56 positions.

Weights are shares of the filer's total reported 13F value, compared with Q1 2026. Share changes may reflect splits; weight changes also reflect price moves. A 13F shows long US-listed positions only, up to 135 days after the fact.

Bronte Capital Management Pty Ltd. 13F holdings
Stock% of 13F valueShare changeReported value
GOOGLAlphabet Inc12.3%-20.0%$109.1M
REGNRegeneron Pharmaceuticals11.4%-5.9%$101.4M
IBKRInteractive Brokers Group in8.7%-31.1%$76.9M
VVisa Inc-Class A Shares8.5%-8.1%$75.5M
BRK-BBerkshire Hathaway Inc Del8.2%-5.9%$73.0M
AMZNAmazon Com Inc7.0%-8.5%$62.3M
PMPhilip Morris Intl Inc6.1%-12.0%$54.3M
CTVACorteva Inc4.4%-9.2%$38.7M
COFCapital One Finl Corp3.9%-7.4%$34.8M
DISDisney Walt Co3.9%+94.0%$34.7M
FCNCAFirst Ctzns Bancshares Cl A3.3%-14.0%$29.5M
TBBBBbb Foods Inc2.5%+9.4%$22.2M
AURAurora Innovation Cl A1.7%-5.7%$14.9M
M8216R110Vaneck ETF Trust1.6%-7.9%$14.5M
SHCSotera Health Co1.6%-5.5%$14.1M
NKTRNektar Therapeutics1.6%+0.1%$13.9M
GHCGraham Hldgs Co Com Cl B1.5%-10.4%$13.1M
IBBIshares Tr1.4%-5.0%$12.5M
BF-BBrown Forman Cl B1.4%—$12.4M
ALNYAlnylam Pharmaceuticals Inc1.2%-5.0%$10.7M
SQMSociedad Quimica Y Minera de1.0%-5.0%$8.6M
GLBEGlobal E Online Ltd0.9%+6.8%$7.9M
NEMNewmont Corp0.7%-7.8%$6.5M
BBarrick Mng Corp0.6%-7.8%$5.4M
RAMPLiveramp Holdings Inc0.5%-42.5%$4.8M
HLFHerbalife Ltd0.5%-65.6%$4.3M
RVMDRevolution Medicines Inc0.4%—$3.5M
TPBTurning Pt Brands Inc0.4%-5.0%$3.5M
IJRIshares Tr0.4%—$3.4M
BBWIBath & Body Works Inc (BBWI)0.4%-7.5%$3.3M
MDLZMondelez International0.3%-4.9%$3.1M
RSKDRiskified Ltd0.3%+20.4%$3.0M
BF-ABrown Forman Corp0.3%-5.0%$2.6M
TYLTyler Technologies Inc0.3%—$2.4M
83601L104Vaneck ETF Trust0.3%-7.5%$2.4M
PCTYPaylocity Hldg Corp0.2%-51.2%$1.9M
NICENice Ltd0.2%-4.1%$1.5M
OLEDUniversal Display Corp0.1%-7.7%$889K
VRSKVerisk Analytics Inc0.1%-7.6%$481K
ENVXEnovix Corporation0.0%+261.6%$93K
TMCITreace Med Concepts Inc0.0%—$62K
FATEFate Therapeutics Inc0.0%-4.9%$59K
ANTXAn2 Therapeutics Inc0.0%—$53K
CCCCC4 Therapeutics Inc0.0%+3.1%$48K
ALXOAlx Oncology Hldgs Inc0.0%—$37K
BLNDBlend Labs, Inc.0.0%—$33K
PEPGPepgen Inc0.0%—$32K
CMRCCommerce.com Inc0.0%—$30K
PACBPacific Biosciences Calif in0.0%—$30K
ABOSAcumen Pharmaceuticals Inc0.0%—$29K

What Bronte Capital Management Pty Ltd. bought and sold in Q2 2026, against Q1 2026.

New positions

Q1 2026's filing was too long to tell new positions apart.

Added to

Share counts compared with the Q1 2026 13F; a split also changes share counts. The latest filing lists more than 50 positions, so a position that left the top 50 may still be held.

How the holdings did against the S&P 500.

1 year
+22.9% /yr
S&P 500 +20.1%
3 years
+20.0% /yr
S&P 500 +20.4%
5 years
+11.2% /yr
S&P 500 +11.6%

A portfolio of the filer's 20 largest 13F positions, weighted by value, bought the trading day after each 13F was filed and held until the next one was: what copying this filer could have earned. 13Fs show long US-listed positions only, so this is an estimate of the stock picks, not the fund's reported returns.

Reported 13F value by quarter.

13F value by quarter
Quarter13F valuePositions
Q2 2026$888.3M56
Q1 2026$940.9M51
Q4 2025$956.8M43
Q3 2025$1.1B29
Q2 2025$1.3B27
Q1 2025$1.2B26
Q4 2024$1.3B24
Q3 2024$1.2B25
Q2 2024$1.3B28
Q1 2024$1.2B29
Q4 2023$1.1B29
Q3 2023$992.8M28

Questions about Bronte Capital Management Pty Ltd.'s portfolio

What stocks does Bronte Capital Management Pty Ltd. own?

Bronte Capital Management Pty Ltd.'s latest 13F, for Q2 2026 and filed Aug 5, 2026, lists 56 positions worth $888.3M. The largest are Alphabet Inc (GOOGL) at 12.3%, Regeneron Pharmaceuticals (REGN) at 11.4%, Interactive Brokers Group in (IBKR) at 8.7%, Visa Inc-Class A Shares (V) at 8.5% and Berkshire Hathaway Inc Del (BRK-B) at 8.2%.

What did Bronte Capital Management Pty Ltd. buy last quarter?

In Q2 2026, Bronte Capital Management Pty Ltd. added Enovix Corporation (ENVX) (+261.6% shares), Disney Walt Co (DIS) (+94.0% shares) and Riskified Ltd (RSKD) (+20.4% shares), compared with its Q1 2026 filing.

What did Bronte Capital Management Pty Ltd. sell last quarter?

In Q2 2026, Bronte Capital Management Pty Ltd. cut from its top 50 Brown Forman Corp, cut from its top 50 Ishares Tr (IWO), cut from its top 50 Pinterest Inc (PINS), cut from its top 50 Sally Beauty Hldgs Inc (SBH), cut from its top 50 James River Group Holdings (JRVR), Herbalife Ltd (HLF) (-65.6% shares), Paylocity Hldg Corp (PCTY) (-51.2% shares) and Liveramp Holdings Inc (RAMP) (-42.5% shares), compared with its Q1 2026 filing.

How has Bronte Capital Management Pty Ltd.'s portfolio performed?

A portfolio copying Bronte Capital Management Pty Ltd.'s 20 largest 13F holdings each quarter, from the day each filing was public, returned +20.0% a year over the last 3 years, against +20.4% for the S&P 500. Over 1 year: +22.9% against +20.1%. Over 5 years: +11.2% a year against +11.6%.

When is Bronte Capital Management Pty Ltd.'s next 13F filing due?

13F filings are due 45 days after each quarter ends. Bronte Capital Management Pty Ltd.'s filing for the quarter ending Sep 30, 2026 is due by Nov 14, 2026; this page updates the day after it is published.

How much money does Bronte Capital Management Pty Ltd. manage?

Bronte Capital Management Pty Ltd. reported $2.3B of regulatory assets under management on its latest SEC Form ADV. Its 13F, which covers only US-listed stocks and options, totals $888.3M.